Assessing adherence and persistence to non-vitamin K antagonist oral anticoagulants (NOACs) among patients with atrial fibrillation in tertiary-care referral centers in Malaysia

Assessing adherence and persistence to non-vitamin K antagonist oral anticoagulants (NOACs) among patients with atrial fibrillation in tertiary-care referral centers in Malaysia

Introduction: Non-vitamin K antagonist oral anticoagulants (NOACs), such as dabigatran and rivaroxaban, are now available for stroke prevention in patients with atrial fibrillation (AF) and are often clinically preferred over vitamin K antagonists (VKAs), such as warfarin. Data describing adherence...

Full description

Bibliographic Details
Main Authors: Mohammed A Kubas, Fatiha Hana Shabaruddin, Wardati Mazlan-Kepli, Nirmala Jagan, Sahimi Mohamed, Nor Ilyani Mohamed Nazar, Che Suraya Zin
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Journal of Pharmacy and Bioallied Sciences
Subjects:
atrial fibrillation
malaysia
medication adherence
noacs
non-vitamin k antagonist oral anticoagulants
oacs
oral anticoagulants
Online Access:http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2020;volume=12;issue=6;spage=781;epage=786;aulast=Kubas

Internet

http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2020;volume=12;issue=6;spage=781;epage=786;aulast=Kubas

Similar Items